The Biotechnology Industry Organization (BIO) will hold its 2012 International Convention in Boston on June 18-21, 2012, just steps away from our Boston office. This leading life-science industry convention draws over 20,000 attendees, who represent more than 4,000 biopharmaceutical companies from over 65 countries. They will come here, to Boston, to connect, partner, and to showcase their products and ideas. To learn more about BIO2012, visit convention.bio.org.
Nutter is privileged to welcome attendees of BIO2012 to its neighborhood. The Boston area is recognized as a thriving biotech “supercluster,” a home to more than 400 biotech companies and many top-tier universities.
Nutter will also host several networking receptions and industry fora that will gather leaders of the biotechnology industry, including investors, executives, and intellectual property counsel. To inquire about these events and our involvement, please contact your Nutter attorney or email
Nutter BIO Events
June 18 – 21
Nutter Sponsors Xconomy BIO TweetChat Series with Luke Timmerman
*Schedule is subject to change.
Monday June 18 at 8am ET – Richard Pops, CEO Alkermes
Monday, June 18, Noon ET – John Maraganore, CEO Alnylam
Tuesday, June 19, Noon ET – Katrine Bosley, CEO Avila
Wednesday, June 20, Noon ET – Deborah Dunsire, CEO Millennium
Thursday, June 21, 10:30 am ET – Jim Greenwood, President & CEO BIO
Nutter is hosting the Locust Walk Partners - 2012 BIO International Conference CEO Breakfast (Invitation only)
Boston Patent Law Association (BPLA) Biotechnology Committee - Biotech and Pharma IP Forum
Nutter is hosting the forum. Topics will include implementation of the patent reform; view from the Patent Office; BIO's IP initiatives; role of IP counsel in the biotech and pharma industry. A reception will follow the panel discussion.
Cocktails on the Waterfront to Celebrate BIO in Boston (Invitation only). To inquire about this event, please contact your Nutter attorney or email
Xconomy BIO Debrief VIP Networking Reception Sponsorship
Nutter McClennen & Fish serves as counsel to leading pharmaceutical, medical device and biotechnology companies in a range of legal areas including intellectual property, corporate finance and transactions, litigation, employment and real estate. The firm also works with emerging companies in these industries to help them realize value from innovation, supporting them with strategic legal advice and counsel in corporate, IP and other areas critical to start-up and acceleration.